Principal Scientist, Late-Stage Upstream Process Development

Posted 19 Days Ago
Be an Early Applicant
Redwood City, CA
160K-185K Annually
Senior level
Biotech
The Role
Lead the late-stage upstream process development for AAV gene therapy by optimizing and scaling up processes for clinical and commercial manufacturing, ensuring compliance with GMP regulations, and collaborating with cross-functional teams.
Summary Generated by Built In

Note to Recruiters and Agencies

The Talent Acquisition / HR team manages the recruiting for all positions at Adverum. We only accept resumes from search agencies or recruiters if the Talent Acquisition / HR team has formally requested your help and have a signed agreement in place. Unsolicited resumes sent to Adverum will be considered property of Adverum. The company will not be responsible for any associated fees should Adverum hire from unsolicited resumes. We request that recruiters do not to contact or present candidates directly to our hiring managers or employees. Doing so may jeopardize the candidate’s eligibility to work on future positions. Recruiters interested in working with Adverum can submit their information to [email protected]. Should we have a tough-to-fill role, we will contact you directly if you specialize in the needed area.


Adverum is looking for a Principal/Senior Pr. Scientist, Late-Stage Upstream Process Development to join the Process Development team at our Redwood City, CA office. The individual will be responsible for leading late-stage upstream process development for adeno-associated virus (AAV) gene therapy programs. The successful candidate will drive the design, optimization, and scale-up of upstream processes to support clinical and commercial manufacturing. This role requires a deep understanding of cell culture, bioreactor and AMBR systems, and gene therapy-specific challenges in AAV vector production, as well as experience in transitioning processes to GMP-compliant manufacturing.

What you'll do:

  • Lead the late-stage development and optimization of upstream processes for AAV production, ensuring scalability, reproducibility, and compliance with regulatory standards.
  • Design and execute experiments to optimize cell culture conditions, transfection parameters, and bioreactor performance.
  • Develop scalable upstream processes compatible with GMP requirements, including suspension cell culture systems.
  • Collaborate with cross-functional teams in analytical development, downstream processing, quality control, and regulatory affairs to ensure seamless transition from development to production.
  • Provide technical expertise in troubleshooting and resolving upstream process issues, working closely with manufacturing teams.
  • Support process characterization/validation studies (including FMEA, scale-down model establishment and DOE/OFAT approach to identify critical process parameters) and process performance qualification, including review of development, manufacturing, process characterization and validation protocols and reports.
  • Support the development and implementation of an (upstream and downstream) process monitoring/control strategy program using appropriate statistical guidelines.
  • Author and review technical documents, including development reports, SOPs, and CMC sections for regulatory filings.
  • Stay updated on industry trends and emerging technologies in gene therapy manufacturing to maintain best-in-class process development practices.
  • Manage internal lab operations and lead direct reports.

About you:

  • Ph.D. in Biochemistry, Chemical Engineering, Molecular Biology, or related field with 6+ years of relevant experience in upstream process development; or M.S. with 8+ years of experience.
  • Proven experience in AAV or other viral vector production, particularly in late-stage development for clinical/commercial scale manufacturing.
  • Strong expertise in cell culture, bioreactor design and operation, and viral vector transfection techniques.
  • Experience with scalable, single-use bioreactor and AMBR systems.
  • Knowledge of GMP requirements and regulatory guidelines for gene therapy products.
  • Must-have advanced knowledge of DOE principles, process characterization, and BLA enabling activities.
  • Background in authoring sections of regulatory submissions, including IND, or BLA filings.
  • Excellent problem-solving skills with the ability to troubleshoot and optimize complex bioprocesses.
  • Strong communication and leadership skills to manage cross-functional projects and mentor team members.

Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum’s core capabilities include clinical development, novel vector discovery and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control.

At Adverum, Inclusion and Diversity are at our core. We believe in the power of being your authentic self. We strive to create the space which allows for everyone in our Adverum Community to not only feel safe but encouraged to speak, learn from each other, grow in their professions and be the very best versions of themselves no matter what their age, ethnic background, gender, origin, religion, or sexual orientation.

Top Skills

Biochemistry
Chemical Engineering
Molecular Biology
The Company
Redwood City, CA
139 Employees
On-site Workplace
Year Founded: 2012

What We Do

Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its novel gene therapy candidate, ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022), as a one-time, IVT injection for patients with neovascular or wet age-related macular degeneration. By overcoming the challenges associated with current treatment paradigms for these debilitating ocular diseases, Adverum aspires to transform the standard of care, preserve vision, and create a profound societal impact around the globe.

Similar Jobs

Kikoff Logo Kikoff

Operations Data Analyst

Fintech • Financial Services
Hybrid
San Francisco, CA, USA
110 Employees
110K-160K Annually

Square Logo Square

Senior Analyst, Marketing Science & Analytics

eCommerce • Fintech • Hardware • Payments • Software • Financial Services
Remote
Hybrid
San Francisco, CA, USA
12000 Employees
108K-203K Annually

BlackLine Logo BlackLine

Procurement Operations Analyst

Cloud • Fintech • Information Technology • Machine Learning • Software • App development • Generative AI
Hybrid
Los Angeles, CA, USA
1810 Employees
85K-114K Annually

Philo Logo Philo

Head of Data

Cloud • Digital Media • News + Entertainment • On-Demand
Easy Apply
Remote
San Francisco, CA, USA
160 Employees

Similar Companies Hiring

Pfizer Thumbnail
Pharmaceutical • Natural Language Processing • Machine Learning • Healthtech • Biotech • Artificial Intelligence
New York, NY
121990 Employees
Takeda Thumbnail
Software • Pharmaceutical • Manufacturing • Healthtech • Biotech • Analytics
Cambridge, MA
50000 Employees
Asimov Thumbnail
Machine Learning • Design • Biotech • Artificial Intelligence
Boston, MA
95 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account